See also this year's filing and all EDGAR filings for this company.
PDF Report 0001126234_2023_LUMOS_PHARMA_INC.pdf
Logs
| warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': inf, 'aggregate_val': 1523000, 'exp_sum': 0, 'exp_to_value': {'remainder_Revenues': 0}} |
Graph
Absolute values for 0001126234, LUMOS PHARMA INC.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 72,009,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 53,000 |
| 3 | remainder_Assets | 230,000 |
| 4 | LiabilitiesCurrent | 6,708,000 |
| 5 | LiabilitiesNoncurrent | 6,000,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 15,706,000 |
| 9 | ResearchAndDevelopmentExpense | 17,857,000 |
| 10 | remainder_Expenses | -13,000 |
| 11 | remainder_Revenues | 1,523,000 |
| 12 | remainder_NetIncome | 965,000 |
| 13 | remainder_ComprehensiveNetIncome | -9,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 72,292,000 |
| 1 | Liabilities | 12,708,000 |
| 2 | Expenses | 33,550,000 |
| 3 | Revenues | 1,523,000 |
| 4 | StockholdersEquity | 59,584,000 |
| 5 | NetIncome | -31,062,000 |
| 6 | ComprehensiveNetIncome | -31,066,500 |
| 7 | BaseVar | 60,523,500 |
| 8 | EconomicCapitalRatio | 1.68 |
Edgar->Model Mapping
Feature Distribution
Change over Time
